Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.
Source | Last Updated |
---|---|
Alliance of Genome Resources | October 9, 2024 |
Disease ID | Disease Name | Alliance of Genome Resources ID | Species | Gene ID | Gene Symbol ▲ | FlyGlycoDB | Evidence Code Names | References |
---|---|---|---|---|---|---|---|---|
DOID:10286 | prostate carcinoma | Xenbase:XB-GENE-6252323 | Xenopus laevis (African clawed frog) | 397873 | bmp2.L |
|
||
DOID:8398 | osteoarthritis | Xenbase:XB-GENE-6252323 | Xenopus laevis (African clawed frog) | 397873 | bmp2.L |
|
||
DOID:0080404 | orofacial cleft 11 | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:668 | myositis ossificans | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:5394 | prolactinoma | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:182 | calcinosis | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:0111805 | syndromic microphthalmia 6 | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:1222 | cartilage disease | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:10286 | prostate carcinoma | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:1909 | melanoma | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:9296 | cleft lip | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:1612 | breast cancer | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:4448 | macular degeneration | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:12185 | otosclerosis | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:11963 | esophagitis | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:9206 | Barrett's esophagus | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:0080205 | CAKUT | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:0111535 | progressive osseous heteroplasia | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:1882 | atrial heart septal defect | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:4450 | renal cell carcinoma | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:0060887 | ossification of the posterior longitudinal ligament of spine | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:10126 | keratoconus | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:0080207 | CAKUT2 | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:13515 | tuberous sclerosis | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
||
DOID:540 | strabismus | Xenbase:XB-GENE-6254046 | Xenopus laevis (African clawed frog) | 399322 | bmp4.S |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024